Article Archive

Article archive

Flowmeter approved by Chinese metrology institute

The HPLC flowmeter is a modern alternative to the traditional flow calibration method

Life-science professionals raise concerns about AI

A recent survey found that issues include data integrity and interoperability

Launch of 3D product using short collagen fibres

To help retain shape and durability of cellular constructs

High speed camera chosen by university researchers

The camera helps with materials testing under high-impact loading

New reagent kits to empower cell therapy development

Biotechnology specialist Applied Cells has launched its Mars Ingenuity Reagent kits for fast and easy cell isolation. This product line features both RUO and GMP-grade reagents, and has been specifically optimised for use on Applied Cells’ proprietary Mars Bar platform.

The platform provides in-flow Immunomagnetic cell isolation technology. The system offers positive and negative cell selection workflows, ensuring the separation of target cell subpopulations with purity, recovery, and viability.

FDA-approved drug targets tissue factor in cervical cancer

  On April 29th, 2024, the FDA in the US granted full approval for  biotechnology company Seagen Inc.'s Tivdak (tisotumab vedotin) product, targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy.

New batch photoreactor will scale up reactions

Designed for scientists creating batch photochemistry reactions

Patient AI-drive trial accelerator launched

The product will unlock a patient-centric approach to trial design

New high-speed actuators for micro and nano dispensing applications

Standard and custom-designed actuators are available

Antibody markers and dye range expanded

The series will enhance immunology research

Camera lens provides switchable day / night vision operation

Custom lens provides optimised solution

International lab purchase backed by private equity

UK based pharma testing group purchases US based anti-cancer outfit in seven-figure deal

First sales of low carbon acetonitrile announced

Low carbon solution offers alternative to traditional acentonitrile

Extended diagnostic solutions on show at trade fair

Products aid with microbial identification, early sepsis diagnosis and more

FDA approves one-time hemophilia treatment

Drug treats adults with moderate to severe hemophilia B

Stable cell line development service launched

Product significantly increases the production of lentivirals

Enhanced expansion medium for stem cell culture launched

Biotechnology company Amsbio has launched an enhanced GMP-compliant version of its animal-origin-free, chemically defined StemFit iPSC expansion medium.

Called StemFit Basic04 CT, the product is designed to improve the growth and pluripotency of induced pluripotent stem cells (iPSC) and meet the Good Manufacturing Practice (GMP) standards for Active Pharmaceutical Ingredients (API).

Things to know about CAR-MA therapy development

This article explores biotechnology Creative Biolabs transformative CAR-macrophage (CAR-MA) therapy discovery services.

Collaboration to leverage drug substance discovery

A year on, the partnership yields dividends

Tube recapping tool increases throughput

For use in biobanking, compound libraries and other applications

Pages

Recent Issues